Close

Genome Valley emerges as Indias Top Life Sciences Cluster

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Ensuring optimal product integrity with pharmaceutical preservation strategies

Preserving the potency of pharmaceutical products is paramount in...

How Stem Cell Therapy Works for the Individual

Stem cell therapy has emerged as one of the...

Tjoapack Expands Injectable Packaging Capabilities Globally

Increased Capabilities in the United States Tjoapack is finishing up...

World Pharma Today / News / India – Genome Valley, Hyderabad by shipping one-third of the world’s vaccine demand among children has beaten Chennai and Bengaluru to become India’s top life sciences cluster. It is considered by many as Asia’s answer to the Boston Life Sciences Corridor, the US cluster which happens to be largest globally. Driving this massive supply of vaccines here are Pharma majors such as Bharat Biotech, Shantha Biotechnics, Indian Immunologicals Limited, and Biological E and many more. Vaccines supplied from here include Tetanus-Diphtheria (combination), Pentavalent, Japanese Encephalitis, Rotavirus, Typhoid Conjugate, and Hepatitis B&C.

This cluster is located at around 60 kms. from the city and houses 200 major firms that have more than 10000 employees working. India contributes 70% of the world’s vaccine market. There has been a significant amount of investment which Genome Valley has been able to draw in the last three years. The investment hovers between 6000-6500 crores which is massive. Besides, there are many top-end brands from Switzerland, Canada, and India that are making their way into the cluster.

Latest stories

Related stories

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Ensuring optimal product integrity with pharmaceutical preservation strategies

Preserving the potency of pharmaceutical products is paramount in...

How Stem Cell Therapy Works for the Individual

Stem cell therapy has emerged as one of the...

Tjoapack Expands Injectable Packaging Capabilities Globally

Increased Capabilities in the United States Tjoapack is finishing up...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back